1.OBJECTIVE: To evaluate the efficiency and safety of partial dopamine re ceptor agonist in clinical application.

1.评价胺受体激动剂临床性。

2.Adverse effects associated with short-term gonadorelin agonists are common, but are rarely serious enough to require drug withdrawal.

2.短期促性腺激素释放因子治相关副作用是常见，但严重到足以停药程度是罕见。

3.Ropinirole,a dopamine agonist,has similar effect of dopamine but without ergoline structure by which its stronger binding power with dopamine D2 receptor may be explained.

3.罗匹尼罗是一种类胺胺激动剂，与第一代胺激动剂不同是没有麦角林结构。罗匹尼罗非麦角林结构可以说明其与胺D2受体有较高结合力。